HLN - Haleon plc - Stock Price & Dividends
Exchange: USA Stocks • Country: United Kingdom • Currency: USD • Type: Common Stock • ISIN: US4055521003
Toothpaste, Mouthwash, Vitamins, Supplements, Pain Relievers, Antacids
Haleon plc is a leading consumer healthcare company that develops, manufactures, and sells a wide range of products to promote health and wellness. With a presence in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific, the company caters to diverse consumer needs across the globe.
The company's oral health portfolio includes popular brands such as Sensodyne, Polident, Parodontax, and Biotene, offering toothpastes, mouthwashes, and denture care products that help people maintain good oral hygiene and prevent oral health issues. Additionally, Haleon provides vitamins, minerals, and supplements under the Centrum, Emergen-C, and Caltrate brands, supporting overall health and nutrition.
Haleon's over-the-counter (OTC) products address various health concerns, including respiratory issues, pain relief, and digestive health. The company's Otrivine, Theraflu, and Flonase brands offer nasal drops and cold, flu, and allergy relief products, while Voltaren, Panadol, and Advil brands provide anti-inflammatory and pain relief solutions. For digestive health, Haleon offers antacids and antihistamine products under the TUMS, ENO, and Fenistil brands.
With a rich history dating back to 1715, Haleon plc was formerly known as DRVW 2022 plc before adopting its current name in February 2022. Headquartered in Weybridge, the United Kingdom, the company continues to innovate and expand its product portfolio to meet the evolving needs of consumers worldwide. For more information, visit https://www.haleon.com.
Drawdown (Underwater) Chart
Overall Trend and Yearly Seasonality
HLN Stock Overview
Market Cap in USD | 48,567m |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
GiC SubIndustry | Biotechnology |
TER | 0.00% |
IPO / Inception | 2022-07-22 |
HLN Stock Ratings
Growth 5y | 71.4 |
Fundamental | 20.0 |
Dividend | 33.2 |
Rel. Performance vs Sector | -1.70 |
Analysts | 4.25/5 |
Fair Price Momentum | 10.16 USD |
Fair Price DCF | 7.60 USD |
HLN Dividends
Dividend Yield 12m | 1.57% |
Yield on Cost 5y | 2.16% |
Dividends CAGR 5y | 0.00% |
Payout Consistency | 100.0% |
HLN Growth Ratios
Growth 12m | 22.82% |
Growth Correlation 12m | 84.7% |
Growth Correlation 3m | 71.8% |
CAGR 5y | 14.94% |
CAGR/Mean DD 5y | 2.31 |
Sharpe Ratio 12m | 0.95 |
Alpha vs SP500 12m | 15.39 |
Beta vs SP500 5y weekly | 0.08 |
ValueRay RSI | 7.66 |
Volatility GJR Garch 1y | 20.39% |
Price / SMA 50 | -2.25% |
Price / SMA 200 | 12.64% |
Current Volume | 3093.7k |
Average Volume 20d | 7638.3k |
External Links for HLN Stock
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
As of October 22, 2024, the stock is trading at USD 9.98 with a total of 3,093,671 shares traded.
Over the past week, the price has changed by -1.19%, over one month by -5.13%, over three months by +12.47% and over the past year by +22.97%.
According to ValueRays Forecast Model, HLN Haleon plc will be worth about 11 in October 2025. The stock is currently trading at 9.98. This means that the stock has a potential upside of +9.92%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 11.4 | 13.9 |
Analysts Target Price | 9.3 | -7.31 |
ValueRay Target Price | 11 | 9.92 |